Effects of artificial liver support system on patients with acute or chronic liver failure. (Q51295376)

2 April 2018

title

Effects of artificial liver support system on patients with acute or chronic liver failure. (English)

1 reference

2 April 2018

author name string

Du WB

1

1 reference

2 April 2018

Li LJ

2

1 reference

2 April 2018

Huang JR

3

1 reference

2 April 2018

Yang Q

4

1 reference

2 April 2018

Liu XL

5

1 reference

2 April 2018

Li J

6

1 reference

2 April 2018

Chen YM

7

1 reference

2 April 2018

Cao HC

8

1 reference

2 April 2018

Xu W

9

1 reference

2 April 2018

Fu SZ

10

1 reference

2 April 2018

Chen YG

11

1 reference

2 April 2018

language of work or name

English

0 references

publication date

1 December 2005

1 reference

2 April 2018

Transplantation Proceedings

published in

1 reference

2 April 2018

volume

37

1 reference

2 April 2018

issue

10

1 reference

2 April 2018

page(s)

4359-4364

1 reference

2 April 2018

Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Fulminant hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Liver transplantation for acute hepatic failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Acute hepatic failure: a Western perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Liver transplantation for fulminant hepatic failure in the pediatric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Resection versus transplantation for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

High volume plasma exchange in fulminant hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Survival rate in children with fulminant hepatitis improved by a combination of twice daily plasmapheresis and intensive conservative therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Plasmapheresis with Albumin as Main Substitute in Acute Hepatic Coma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Continuous removal of middle molecules by hemofiltration in patients with acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Review of methods to remove protein-bound substances in liver failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

A model to predict survival in patients with end-stage liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Longitudinal assessment of mortality risk among candidates for liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Critical care apheresis: hepatic failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.11.044

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSPROCEED.2005.11.044

1 reference

2 April 2018

PubMed ID

16387120

1 reference

2 April 2018